Your Search Results

M-TEER for primary mitral regurgitation

08 Feb 2025 – From PCR Tokyo Valves 2025

In this PCR Tokyo Valves 2025 session on M-TEER for primary mitral regurgitation, gain valuable insights starting with an overview of current TEER devices. Benefit from four case studies that highlight the features of these devices, explore strategies to prevent mitral regurgitation recurrence post-TEER, and delve...

M-TEER around the world

08 Feb 2025 – From PCR Tokyo Valves 2025

Explore the latest insights and advancements in the field of Mitral Transcatheter Edge-to-Edge Repair (M-TEER) from around the world. Discover a new anatomical risk score for predicting procedural outcomes, two-year outcomes from the MiCLASP study, the impact of regurgitant volume to left atrial volume ratio on...

M-TEER difficult situation: small mitral valves, P2 prolapse & leaflet degeneration

08 Feb 2025 – From PCR Tokyo Valves 2025

Explore a series of challenging cases in Mitral Transcatheter Edge-to-Edge Repair (M-TEER), highlighting the versatility and adaptability of this technique. Discover how M-TEER can be successfully applied in patients with extremely small mitral valves, P2 prolapse supported by chordae from the posterior papillary muscle, wide prolapse...

M-TEER difficult situation: small mitral valves, P2 prolapse & leaflet degeneration

TAVI complications: hemolytic anemia, prosthetic valve endocarditis & stroke

08 Feb 2025 – From PCR Tokyo Valves 2025

Gain valuable insights into the management of complications associated with Transcatheter Aortic Valve Implantation (TAVI). Discover the latest evidence on hemolytic anemia, the predictive value of the hemoglobin to creatinine ratio, outcomes of transcarotid TAVI, a case study on prosthetic valve endocarditis, the role of diastolic...

TAVI complications: hemolytic anemia, prosthetic valve endocarditis & stroke

ACST-2 (Second asymptomatic carotid surgery trial): stenting vs. surgery for tight carotid stenosis

26 Aug 2021

Ali Nazmi Calik and Pascal Meier review this trial comparing CEA with CAS for patients with asymptomatic carotid stenosis, which was presented by Alison Halliday (Oxford, United Kingdom of Great Britain & Northern Ireland) during a Hot Line session of the ESC Congress 2021.